WWOX Gene Spinocerebellar Ataxia Type 12 Autosomal Recessive Genetic Test
At DNA Labs UAE, we offer the WWOX Gene Spinocerebellar Ataxia Type 12 Autosomal Recessive Genetic Test. This test is designed to diagnose Spinocerebellar Ataxia Type 12 (SCA12), a genetic disorder that affects the cerebellum and causes movement coordination problems.
Test Components and Price
The WWOX Gene Spinocerebellar Ataxia Type 12 Autosomal Recessive Genetic Test is priced at 4400.0 AED. The test requires a blood sample or extracted DNA, or one drop of blood on an FTA card.
Report Delivery
After the sample is collected, the report will be delivered within 3 to 4 weeks.
Method
The test utilizes NGS (Next-Generation Sequencing) technology to analyze multiple genes simultaneously.
Test Type
The WWOX Gene Spinocerebellar Ataxia Type 12 Autosomal Recessive Genetic Test falls under the category of Neurological Disorders.
Doctor and Test Department
The test is conducted by a Neurologist and falls under the Genetics department.
Pre Test Information
Before undergoing the WWOX Gene Spinocerebellar Ataxia Type 12 Autosomal Recessive Genetic Test, it is important to provide the clinical history of the patient. Additionally, a Genetic Counselling session will be conducted to draw a pedigree chart of family members affected with SCA12.
Test Details
SCA12 is caused by mutations in the WWOX gene, which is involved in various cellular processes including DNA repair, apoptosis, and tumor suppression. The NGS genetic test can identify these mutations and confirm a diagnosis for individuals suspected of having SCA12 based on their symptoms and family history.
An autosomal recessive inheritance pattern means that an individual must inherit two copies of the mutated gene (one from each parent) to develop the disorder. If only one copy is inherited, the person is considered a carrier and does not typically show symptoms.
The NGS genetic test for SCA12 can also be used for carrier testing in individuals with a family history of SCA12 or for prenatal testing in families with a known mutation.
The test involves obtaining a DNA sample, usually through a blood sample or cheek swab, and analyzing the DNA for mutations in the WWOX gene using NGS technology.
The results of the test can help with diagnosis, prognosis, and genetic counseling for affected individuals and their families. It is important to consult with a healthcare professional or genetic counselor to discuss the specific details and implications of the NGS genetic test for SCA12, as they can provide personalized information and guidance based on the individual’s situation.
| Test Name | WWOX Gene Spinocerebellar ataxia type 12 autosomal recessive Genetic Test |
|---|---|
| Components | |
| Price | 4400.0 AED |
| Sample Condition | Blood or Extracted DNA or One drop Blood on FTA Card o |
| Report Delivery | 3 to 4 Weeks |
| Method | NGS Technology |
| Test type | Neurological Disorders |
| Doctor | Neurologist |
| Test Department: | Genetics |
| Pre Test Information | Clinical History of Patient who is going for WWOX Gene Spinocerebellar ataxia type 12, autosomal recessive NGS Genetic DNA Test A Genetic Counselling session to draw a pedigree chart of family members affected with WWOX Gene Spinocerebellar ataxia type 12, autosomal recessive |
| Test Details | Spinocerebellar ataxia type 12 (SCA12) is a genetic disorder that affects the cerebellum and causes problems with movement coordination. It is caused by mutations in the WWOX gene, which is involved in various cellular processes including DNA repair, apoptosis, and tumor suppression. NGS (Next-Generation Sequencing) genetic testing is a type of genetic testing that uses advanced sequencing technologies to analyze multiple genes simultaneously. It can be used to identify mutations in the WWOX gene associated with SCA12. An autosomal recessive inheritance pattern means that an individual must inherit two copies of the mutated gene (one from each parent) in order to develop the disorder. If only one copy is inherited, the person is considered a carrier and does not typically show symptoms. The NGS genetic test for SCA12 can be used to confirm a diagnosis in individuals suspected of having the disorder based on their symptoms and family history. It can also be used for carrier testing in individuals with a family history of SCA12 or for prenatal testing in families with a known mutation. The test involves obtaining a DNA sample, usually through a blood sample or cheek swab, and analyzing the DNA for mutations in the WWOX gene using NGS technology. The results of the test can help with diagnosis, prognosis, and genetic counseling for affected individuals and their families. It is important to consult with a healthcare professional or genetic counselor to discuss the specific details and implications of the NGS genetic test for SCA12, as they can provide personalized information and guidance based on the individual’s situation. |
